Does INTERFERON BETA-1B Cause Mobility decreased? 150 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Mobility decreased have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 1.2% of all adverse event reports for INTERFERON BETA-1B.
150
Reports of Mobility decreased with INTERFERON BETA-1B
1.2%
of all INTERFERON BETA-1B reports
6
Deaths
39
Hospitalizations
How Dangerous Is Mobility decreased From INTERFERON BETA-1B?
Of the 150 reports, 6 (4.0%) resulted in death, 39 (26.0%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which INTERFERON BETA-1B Alternatives Have Lower Mobility decreased Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS